Iceland· IS-EU/1/20/1446/001
Hepcludex
A bulevirtide product containing bulevirtidum inn, registered in Iceland by Gilead Sciences Ireland UC*. The same ATC class is registered in 14 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Bulevirtide is registered in 14 of 19 countries.
Countries holding a registration under ATC J05AX28 (bulevirtide), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 10 of them publish a price we can compare per daily dose
Bulevirtide · ATC J05AX28
14 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of bulevirtide costs, country by country.
Normalised to the WHO defined daily dose (2 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Bulevirtide · price per daily dose (2 mg)
USD · FX 28 Sept 2026
- CH Switzerland$219.16
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Bulevirtidum INN
- Manufacturer
- Gilead Sciences Ireland UC*
- Country
- Iceland (IS)
- ATC code
- J05AX28
- ATC class
- Bulevirtide
- Defined daily dose
- 2 mg, P
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 1
1 priced- ean98361130 hgl x1 pakkiISK 1355605
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bulevirtide in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainHEPCLUDEX 2 MG POLVO PARA SOLUCION INYECTABLEGilead Sciences Ireland Unlimited Company
- United KingdomHepcludex 2mg powder for solution for injection vialsGilead Sciences Ltd
- NorwayHepcludexGilead Sciences Ireland UC
- PolandHepcludexGilead Sciences Ireland UC
- SwedenHEPCLUDEX 2 mg Pulver till injektionsvätska, lösningGilead Sciences Ireland UC
- FranceHEPCLUDEX 2 mg, poudre pour solution injectableGILEAD SCIENCES IRELAND UC (IRLANDE)
- IrelandHEPCLUDEX 2 mg powder for solution for injectionGilead Sciences Ireland UC
- ItalyHEPCLUDEX*30 flaconcini SC polv 2 mgGILEAD SCIENCES IRELAND UC
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Liechtenstein · Hepcludex
- Norway · Hepcludex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a2df031c-bcd3-461a-b429-7878adc3213c GET /v1/drugs/a2df031c-bcd3-461a-b429-7878adc3213c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Stungulyfsstofn, lausn",
"source": "lyfjastofnun",
"atc_raw": "J05AX28",
"marketed": false,
"strength": "2 mg",
"ma_number": "EU/1/20/1446/001",
"substance": "Bulevirtidum INN",
"other_info": "Ávísun lyfsins er bundin við sérfræðinga í meltingar- eða smitsjúkdómum.",
"legal_status": "(R Z) Sérfræðingsmerkt (og lyfseðilsskylt)",
"ma_issued_serial": "44043"
}See everything about bulevirtide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.